Profitability Ratios
| Ratio |
Value |
| GP Margin |
70.3% |
| EBIT Margin |
16.3% |
| EBITDA Margin |
24.1% |
| Operating Margin |
24.7% |
| Pretax Margin |
12.0% |
| Cont. Ops Margin |
12.4% |
| Net Margin |
12.4% |
| Bottom Line Margin |
12.4% |
Liquidity Ratios
| Ratio |
Value |
| Current Ratio |
1.16 |
| Quick Ratio |
0.87 |
| Solvency Ratio |
0.104 |
| Cash Ratio |
0.03 |
Valuation Ratios
| Ratio |
Value |
| Price/Earnings |
|
| PEG Ratio |
-4.33 |
| Forward PEG |
-4.33 |
| Price/Book |
1.64 |
| Price/Sales |
2.26 |
| Price/FCF |
15.59 |
| Price/Op Cash Flow |
12.09 |
Debt Ratios
| Ratio |
Value |
| Debt/Assets |
0.3239 |
| Debt/Equity |
0.7796 |
| Debt/Capital |
0.4381 |
| Long-Term Debt/Capital |
0.4162 |
| Financial Leverage |
2.41 |
Cash Flow Ratios
| Ratio |
Value |
| Working Capital Turnover |
9.43 |
| Operating Cash Flow Ratio |
0.316 |
| Operating Cash Flow/Sales |
18.7% |
| Free Cash Flow/Operating Cash Flow |
77.5% |
Coverage Ratios
| Ratio |
Value |
| Debt Service Coverage |
2.50 |
| Interest Coverage |
5.7795 |
| Short-Term Operating Cash Flow Coverage |
3.36 |
| Operating Cash Flow Coverage |
0.17 |
| Capital Expenditure Coverage |
4.45 |
| Dividend + Capital Expenditure Coverage |
0.94 |
Dividend Ratios
| Ratio |
Value |
| Payout Ratio |
125.7529% |
| Dividend Yield |
6.9053% |
| Dividend Yield % |
6.9053% |
| Dividend Per Share |
1.7194 |
Per Share Ratios
| Ratio |
Value |
| Revenue/Share |
11.01 |
| EPS |
1.367 |
| Debt/Share |
12.3333 |
| Cash/Share |
2.39 |
| Book Value/Share |
15.27 |
| Tangible BV/Share |
-6.73 |
| Equity/Share |
15.22 |
| Operating Cash Flow/Share |
2.060 |
| Capital Expenditure/Share |
0.463 |
| FCF/Share |
1.597 |
Other Ratios
| Ratio |
Value |
| Net Income/Earnings Before Tax |
1.033 |
| Earnings Before Tax/EBIT |
0.487 |
| Price/Fair Value |
1.64 |
| Debt/Market Cap |
0.4602 |
| Effective Tax Rate |
-3.5% |
| Enterprise Value Multiple |
13.76 |
PFE - Pfizer Inc.